共 50 条
- [1] Tumor microenvironment and clinical efficacy of atezolizumab plus bevacizumab for hepatocellular carcinomaANNALS OF ONCOLOGY, 2023, 34 : S1399 - S1399Taira, Tomonao论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, JapanKojima, Motohiro论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Res Ctr Innovat Oncol, Div Pathol, Kashiwa, Chiba, Japan Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, JapanYamaguchi, Shota论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, JapanInoue, Kanae论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, JapanEguchi, Hiroki论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, JapanOkumura, Kei论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, JapanShibuki, Taro论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, JapanSatake, Tomoyuki论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, JapanWatanabe, Kazuo论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, JapanSasaki, Mitsuhito论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, JapanImaoka, Hiroshi论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, JapanMitsunaga, Shuichi论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, JapanIshii, Genichiro论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Pathol & Clin Labs, Kashiwa, Chiba, Japan Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, JapanIkeda, Masafumi论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan
- [2] Atezolizumab plus bevacizumab for advanced, unresectable hepatocellular carcinomaJOURNAL OF BUON, 2021, 26 (02): : 637 - 638Tsilimigras, Diamantis I.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Wexner Med Ctr, Div Surg Oncol, Dept Surg, Columbus, OH 43210 USA Ohio State Univ, Wexner Med Ctr, Div Surg Oncol, Dept Surg, Columbus, OH 43210 USAMoris, Dimitrios论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA Ohio State Univ, Wexner Med Ctr, Div Surg Oncol, Dept Surg, Columbus, OH 43210 USA
- [3] Result of atezolizumab plus bevacizumab for advanced or metastatic hepatocellular carcinoma in Vietnamese patientsANNALS OF ONCOLOGY, 2024, 35 : S88 - S88Hoang, H. T.论文数: 0 引用数: 0 h-index: 0机构: Vietnam Natl Canc Hosp BASE 3, K Hosp, Optimal Clin Care, Hanoi, Vietnam Vietnam Natl Canc Hosp BASE 3, K Hosp, Optimal Clin Care, Hanoi, Vietnam
- [4] Efficacy and safety of atezolizumab plus bevacizumab in Korean patients with advanced hepatocellular carcinomaLIVER INTERNATIONAL, 2022, 42 (03) : 674 - 681Cheon, Jaekyung论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Ulsan Univ Hosp, Dept Hematol Oncol, Coll Med, Ulsan, South Korea CHA Univ, CHA Bundang Med Ctr, Dept Med Oncol, Sch Med, 59 Yatap Ro, Seongnam 13496, South Korea Univ Ulsan, Ulsan Univ Hosp, Dept Hematol Oncol, Coll Med, Ulsan, South Korea论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:Kim, Han Sang论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Brain Korea 21 FOUR Project Med Sci, Dept Internal Med, Div Med Oncol,Coll Med,Yonsei Canc Ctr, Seoul, South Korea Univ Ulsan, Ulsan Univ Hosp, Dept Hematol Oncol, Coll Med, Ulsan, South KoreaLee, Dae-Won论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp, Seoul, South Korea Univ Ulsan, Ulsan Univ Hosp, Dept Hematol Oncol, Coll Med, Ulsan, South Korea论文数: 引用数: h-index:机构:Kim, Jin Won论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Coll Med, Seongnam, South Korea Univ Ulsan, Ulsan Univ Hosp, Dept Hematol Oncol, Coll Med, Ulsan, South Korea论文数: 引用数: h-index:机构:Oh, Sang-Bo论文数: 0 引用数: 0 h-index: 0机构: Pusan Natl Univ, Dept Internal Med, Yangsan Hosp, Yangsan, Gyeongsangnam D, South Korea Univ Ulsan, Ulsan Univ Hosp, Dept Hematol Oncol, Coll Med, Ulsan, South KoreaHwang, Jun-Eul论文数: 0 引用数: 0 h-index: 0机构: Chonnam Natl Univ, Hwasun Hosp, Dept Internal Med, Med Sch, Gwangju, South Korea Univ Ulsan, Ulsan Univ Hosp, Dept Hematol Oncol, Coll Med, Ulsan, South KoreaChon, Hong Jae论文数: 0 引用数: 0 h-index: 0机构: CHA Univ, CHA Bundang Med Ctr, Dept Med Oncol, Sch Med, 59 Yatap Ro, Seongnam 13496, South Korea Univ Ulsan, Ulsan Univ Hosp, Dept Hematol Oncol, Coll Med, Ulsan, South KoreaLim, Ho Yeong论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Sch Med, Seoul, South Korea Univ Ulsan, Ulsan Univ Hosp, Dept Hematol Oncol, Coll Med, Ulsan, South Korea
- [5] PREDICTING RESPONSE TO ATEZOLIZUMAB PLUS BEVACIZUMAB IN ADVANCED HEPATOCELLULAR CARCINOMAHEPATOLOGY, 2023, 78 : S1871 - S1872Cappuyns, Sarah论文数: 0 引用数: 0 h-index: 0机构: Uz KU Leuven, Leuven, Belgium Icahn Sch Med Mt Sinai, New York, NY USA Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain Uz KU Leuven, Leuven, BelgiumPique-Gili, Marta论文数: 0 引用数: 0 h-index: 0机构: Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain Uz KU Leuven, Leuven, BelgiumEsteban-Fabro, Roger论文数: 0 引用数: 0 h-index: 0机构: Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain Uz KU Leuven, Leuven, BelgiumPhilips, Gino论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Leuven, Belgium Uz KU Leuven, Leuven, BelgiumPinyol, Roser论文数: 0 引用数: 0 h-index: 0机构: Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain Uz KU Leuven, Leuven, BelgiumVandecaveye, Vincent论文数: 0 引用数: 0 h-index: 0机构: Uz KU Leuven, Leuven, Belgium Uz KU Leuven, Leuven, BelgiumAbril-Fornaguera, Jordi论文数: 0 引用数: 0 h-index: 0机构: Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain Uz KU Leuven, Leuven, BelgiumHaber, Philipp论文数: 0 引用数: 0 h-index: 0机构: Charite Univ Med Berlin, Berlin, Germany Uz KU Leuven, Leuven, BelgiumVerslype, Chris论文数: 0 引用数: 0 h-index: 0机构: Uz KU Leuven, Leuven, Belgium Uz KU Leuven, Leuven, BelgiumVan Cutsem, Eric论文数: 0 引用数: 0 h-index: 0机构: Uz KU Leuven, Leuven, Belgium Uz KU Leuven, Leuven, BelgiumLambrechts, Diether论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Leuven, Belgium Uz KU Leuven, Leuven, BelgiumVillanueva, Augusto论文数: 0 引用数: 0 h-index: 0机构: Uz KU Leuven, Leuven, BelgiumDekervel, Jeroen论文数: 0 引用数: 0 h-index: 0机构: Uz KU Leuven, Leuven, Belgium Uz KU Leuven, Leuven, BelgiumLlovet, Josep M.论文数: 0 引用数: 0 h-index: 0机构: Icahn Sch Med Mt Sinai, New York, NY USA Uz KU Leuven, Leuven, Belgium
- [6] Association between tumor morphology and efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinomaHEPATOLOGY RESEARCH, 2024, 54 (08) : 773 - 780Ishihara, Nobuaki论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg, Kobe, Japan Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg, Kobe, Japan论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:Ueshima, Eisuke论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Japan Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg, Kobe, JapanYano, Yoshihiko论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Grad Sch Med, Dept Internal Med, Div Gastroenterol, Kobe, Japan Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg, Kobe, JapanFujishima, Yoshimi论文数: 0 引用数: 0 h-index: 0机构: Kobe Minimally Invas Canc Ctr, Div Med Oncol, Kobe, Japan Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg, Kobe, JapanIshida, Jun论文数: 0 引用数: 0 h-index: 0机构: Kobe Minimally Invas Canc Ctr, Div Radiol, Kobe, Japan Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg, Kobe, Japan论文数: 引用数: h-index:机构:Gon, Hidetoshi论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg, Kobe, Japan Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg, Kobe, JapanFukushima, Kenji论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg, Kobe, Japan Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg, Kobe, JapanUrade, Takeshi论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg, Kobe, Japan Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg, Kobe, Japan论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:Ueda, Yoshihide论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Grad Sch Med, Dept Internal Med, Div Gastroenterol, Kobe, Japan Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg, Kobe, JapanKodama, Yuzo论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Grad Sch Med, Dept Internal Med, Div Gastroenterol, Kobe, Japan Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg, Kobe, JapanMurakami, Takamichi论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Japan Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg, Kobe, Japan论文数: 引用数: h-index:机构:
- [7] Tumor steatosis and glutamine synthetase expression in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapyHEPATOLOGY RESEARCH, 2023, 53 (10) : 1008 - 1020Kurebayashi, Yutaka论文数: 0 引用数: 0 h-index: 0机构: Keio Univ, Dept Pathol, Sch Med, 35 Shinanomachi,Shinjuku ku, Tokyo 1600023, Japan Keio Univ, Dept Pathol, Sch Med, 35 Shinanomachi,Shinjuku ku, Tokyo 1600023, JapanTsujikawa, Hanako论文数: 0 引用数: 0 h-index: 0机构: Keio Univ, Dept Pathol, Sch Med, 35 Shinanomachi,Shinjuku ku, Tokyo 1600023, Japan Keio Univ Hosp, Dept Diagnost Pathol, Tokyo, Japan Keio Univ, Dept Pathol, Sch Med, 35 Shinanomachi,Shinjuku ku, Tokyo 1600023, JapanSugimoto, Katsutoshi论文数: 0 引用数: 0 h-index: 0机构: Tokyo Med Univ, Dept Gastroenterol & Hepatol, 6-7-1 Nishi Shinjuku,Shinjuku ku, Tokyo 1600023, Japan Keio Univ, Dept Pathol, Sch Med, 35 Shinanomachi,Shinjuku ku, Tokyo 1600023, JapanYunaiyama, Daisuke论文数: 0 引用数: 0 h-index: 0机构: Tokyo Med Univ, Dept Radiol, Tokyo, Japan Keio Univ, Dept Pathol, Sch Med, 35 Shinanomachi,Shinjuku ku, Tokyo 1600023, JapanAraki, Yoichi论文数: 0 引用数: 0 h-index: 0机构: Tokyo Med Univ, Dept Radiol, Tokyo, Japan Keio Univ, Dept Pathol, Sch Med, 35 Shinanomachi,Shinjuku ku, Tokyo 1600023, JapanSaito, Kazuhiro论文数: 0 引用数: 0 h-index: 0机构: Tokyo Med Univ, Dept Radiol, Tokyo, Japan Keio Univ, Dept Pathol, Sch Med, 35 Shinanomachi,Shinjuku ku, Tokyo 1600023, JapanTakahashi, Hiroshi论文数: 0 引用数: 0 h-index: 0机构: Tokyo Med Univ, Dept Gastroenterol & Hepatol, 6-7-1 Nishi Shinjuku,Shinjuku ku, Tokyo 1600023, Japan Keio Univ, Dept Pathol, Sch Med, 35 Shinanomachi,Shinjuku ku, Tokyo 1600023, JapanKakegawa, Tatsuya论文数: 0 引用数: 0 h-index: 0机构: Tokyo Med Univ, Dept Gastroenterol & Hepatol, 6-7-1 Nishi Shinjuku,Shinjuku ku, Tokyo 1600023, Japan Keio Univ, Dept Pathol, Sch Med, 35 Shinanomachi,Shinjuku ku, Tokyo 1600023, JapanWada, Takuya论文数: 0 引用数: 0 h-index: 0机构: Tokyo Med Univ, Dept Gastroenterol & Hepatol, 6-7-1 Nishi Shinjuku,Shinjuku ku, Tokyo 1600023, Japan Keio Univ, Dept Pathol, Sch Med, 35 Shinanomachi,Shinjuku ku, Tokyo 1600023, JapanTomita, Yusuke论文数: 0 引用数: 0 h-index: 0机构: Tokyo Med Univ, Dept Gastroenterol & Hepatol, 6-7-1 Nishi Shinjuku,Shinjuku ku, Tokyo 1600023, Japan Keio Univ, Dept Pathol, Sch Med, 35 Shinanomachi,Shinjuku ku, Tokyo 1600023, JapanAbe, Masakazu论文数: 0 引用数: 0 h-index: 0机构: Tokyo Med Univ, Dept Gastroenterol & Hepatol, 6-7-1 Nishi Shinjuku,Shinjuku ku, Tokyo 1600023, Japan Keio Univ, Dept Pathol, Sch Med, 35 Shinanomachi,Shinjuku ku, Tokyo 1600023, JapanYoshimasu, Yu论文数: 0 引用数: 0 h-index: 0机构: Tokyo Med Univ, Dept Gastroenterol & Hepatol, 6-7-1 Nishi Shinjuku,Shinjuku ku, Tokyo 1600023, Japan Keio Univ, Dept Pathol, Sch Med, 35 Shinanomachi,Shinjuku ku, Tokyo 1600023, JapanTakeuchi, Hirohito论文数: 0 引用数: 0 h-index: 0机构: Tokyo Med Univ, Dept Gastroenterol & Hepatol, 6-7-1 Nishi Shinjuku,Shinjuku ku, Tokyo 1600023, Japan Keio Univ, Dept Pathol, Sch Med, 35 Shinanomachi,Shinjuku ku, Tokyo 1600023, JapanHirata, Taiki论文数: 0 引用数: 0 h-index: 0机构: Tokyo Med Univ, Dept Gastroenterol & Hepatol, 6-7-1 Nishi Shinjuku,Shinjuku ku, Tokyo 1600023, Japan Keio Univ, Dept Pathol, Sch Med, 35 Shinanomachi,Shinjuku ku, Tokyo 1600023, Japan论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:Nagao, Toshitaka论文数: 0 引用数: 0 h-index: 0机构: Tokyo Med Univ, Dept Anat Pathol, Tokyo, Japan Keio Univ, Dept Pathol, Sch Med, 35 Shinanomachi,Shinjuku ku, Tokyo 1600023, JapanItoi, Takao论文数: 0 引用数: 0 h-index: 0机构: Tokyo Med Univ, Dept Gastroenterol & Hepatol, 6-7-1 Nishi Shinjuku,Shinjuku ku, Tokyo 1600023, Japan Keio Univ, Dept Pathol, Sch Med, 35 Shinanomachi,Shinjuku ku, Tokyo 1600023, JapanSakamoto, Michiie论文数: 0 引用数: 0 h-index: 0机构: Keio Univ, Dept Pathol, Sch Med, 35 Shinanomachi,Shinjuku ku, Tokyo 1600023, Japan Keio Univ, Dept Pathol, Sch Med, 35 Shinanomachi,Shinjuku ku, Tokyo 1600023, Japan
- [8] Atezolizumab plus bevacizumab in Child-Pugh B advanced hepatocellular carcinoma patientsJOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)Kim, Hyeyeong论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Ulsan Univ Hosp, Ulsan, South KoreaCheon, Jaekyung论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Ulsan Univ Hosp, Ulsan, South KoreaHa, Yeongjung论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Ulsan Univ Hosp, Ulsan, South KoreaKim, Han Sang论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Ulsan Univ Hosp, Ulsan, South KoreaKim, Chang Gon论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Ulsan Univ Hosp, Ulsan, South KoreaKim, Ilhwan论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Ulsan Univ Hosp, Ulsan, South KoreaKim, Chan论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Ulsan Univ Hosp, Ulsan, South KoreaJung, Sang-Hoon论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Ulsan Univ Hosp, Ulsan, South KoreaChon, Hong Jae论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Ulsan Univ Hosp, Ulsan, South Korea
- [9] Combination of Radiotherapy and Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Pilot StudyINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E304 - E305Hur, Y. J.论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Yonsei Canc Ctr, Coll Med, Dept Radiat Oncol, Seoul, South Korea Yonsei Univ, Yonsei Canc Ctr, Coll Med, Dept Radiat Oncol, Seoul, South KoreaKim, J.论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Yonsei Canc Ctr, Coll Med, Dept Radiat Oncol, Seoul, South Korea Yonsei Univ, Yonsei Canc Ctr, Coll Med, Dept Radiat Oncol, Seoul, South KoreaSeong, J.论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Yonsei Canc Ctr, Coll Med, Dept Radiat Oncol, Seoul, South Korea Yonsei Univ, Yonsei Canc Ctr, Coll Med, Dept Radiat Oncol, Seoul, South KoreaLee, C. K.论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Yonsei Canc Ctr, Coll Med, Dept Internal Med, Seoul, South Korea Yonsei Univ, Yonsei Canc Ctr, Coll Med, Dept Radiat Oncol, Seoul, South KoreaKim, B. K.论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Yonsei Canc Ctr, Coll Med, Dept Internal Med, Seoul, South Korea Yonsei Univ, Yonsei Canc Ctr, Coll Med, Dept Radiat Oncol, Seoul, South KoreaKim, D. Y.论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Yonsei Canc Ctr, Coll Med, Dept Internal Med, Seoul, South Korea Yonsei Univ, Yonsei Canc Ctr, Coll Med, Dept Radiat Oncol, Seoul, South Korea
- [10] Atezolizumab plus bevacizumab in patients with child-Pugh B advanced hepatocellular carcinomaTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15Cheon, Jaekyung论文数: 0 引用数: 0 h-index: 0机构: CHA Univ, CHA Bundang Med Ctr, Dept Med Oncol, Coll Med, Seongnam, South Korea CHA Univ, CHA Bundang Med Ctr, Dept Med Oncol, 59 Yatap Ro, Seongnam 13496, South KoreaKim, Hyeyeong论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Ulsan Univ Hosp, Dept Hematol Oncol, Coll Med, Ulsan, South Korea CHA Univ, CHA Bundang Med Ctr, Dept Med Oncol, 59 Yatap Ro, Seongnam 13496, South KoreaKim, Han Sang论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Dept Internal Med, Div Med Oncol, Coll Med, Seoul, South Korea CHA Univ, CHA Bundang Med Ctr, Dept Med Oncol, 59 Yatap Ro, Seongnam 13496, South KoreaKim, Chang Gon论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Dept Internal Med, Div Med Oncol, Coll Med, Seoul, South Korea CHA Univ, CHA Bundang Med Ctr, Dept Med Oncol, 59 Yatap Ro, Seongnam 13496, South Korea论文数: 引用数: h-index:机构:Kang, Beodeul论文数: 0 引用数: 0 h-index: 0机构: CHA Univ, CHA Bundang Med Ctr, Dept Med Oncol, Coll Med, Seongnam, South Korea CHA Univ, CHA Bundang Med Ctr, Dept Med Oncol, 59 Yatap Ro, Seongnam 13496, South KoreaKim, Chan论文数: 0 引用数: 0 h-index: 0机构: CHA Univ, CHA Bundang Med Ctr, Dept Med Oncol, Coll Med, Seongnam, South Korea CHA Univ, CHA Bundang Med Ctr, Dept Med Oncol, 59 Yatap Ro, Seongnam 13496, South KoreaJung, Sanghoon论文数: 0 引用数: 0 h-index: 0机构: CHA Univ, CHA Bundang Med Ctr, Dept Radiol, Seongnam, South Korea CHA Univ, CHA Bundang Med Ctr, Dept Med Oncol, 59 Yatap Ro, Seongnam 13496, South KoreaHa, Yeonjung论文数: 0 引用数: 0 h-index: 0机构: CHA Univ, CHA Bundang Med Ctr, Dept Gastroenterol, 59 Yatap Ro, Seongnam 13496, South Korea CHA Univ, CHA Bundang Med Ctr, Dept Med Oncol, 59 Yatap Ro, Seongnam 13496, South KoreaChon, Hong Jae论文数: 0 引用数: 0 h-index: 0机构: CHA Univ, CHA Bundang Med Ctr, Dept Med Oncol, 59 Yatap Ro, Seongnam 13496, South Korea CHA Univ, CHA Bundang Med Ctr, Dept Med Oncol, 59 Yatap Ro, Seongnam 13496, South Korea